Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.
about
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery.Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment.Nanovector.Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.Cholesterylbutyrate solid lipid nanoparticles as a butyric acid prodrug.Amphiphilic poly{[alpha-maleic anhydride-omega-methoxy-poly(ethylene glycol)]-co-(ethyl cyanoacrylate)} graft copolymer nanoparticles as carriers for transdermal drug delivery.Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Solid lipid nanoparticles: an oral bioavailability enhancer vehicle.Natural carriers for application in tuberculosis treatment.Recent approaches of lipid-based delivery system for lymphatic targeting via oral route.Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine.BSA-PLGA-based core-shell nanoparticles as carrier system for water-soluble drugs.Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood-brain barrier.Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion of human neutrophils to endothelial cells.Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticlesPreparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration.Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.Effect of poloxamer 188 on lymphatic uptake of carvedilol-loaded solid lipid nanoparticles for bioavailability enhancement.Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.Pharmacokinetics, tissue distribution and bioavailability of nitrendipine solid lipid nanoparticles after intravenous and intraduodenal administration.Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma
P2860
Q30479638-B7B7490A-0F0E-4498-A736-642608AD4609Q35188633-4276C615-F675-4C10-A968-AD15A5593117Q35596460-1CAF8BA1-F458-4BBE-BF3A-28AB0E014240Q36034107-EF3D9F2B-1247-42DE-8C30-B86FCD15FFE9Q37038862-1AF0493E-52D8-4F8F-B386-0381C99EF60AQ37066550-4A93A887-8247-463D-91BE-D8E473ED9DB2Q37096490-A47458A8-312D-4B21-9DF2-CA34886FB4DCQ37417577-656AEE97-9BA2-44EE-8B7C-BC4F23ADF394Q37490613-17361005-8A4E-4D7A-8E52-4DEB792E00B4Q37646827-7A001241-A228-4833-9F4B-6048C1712E27Q37914880-6FEFA81A-9841-4071-9D2D-7675637F2BCDQ38044741-D9A171A0-5086-4A9B-846A-65907A13A83FQ38242314-3B0766AC-7057-4F8E-A883-BBB8275B2FEEQ38558905-112708AF-4BD6-43E8-B691-DF28752495BBQ39140858-DACE8452-DB69-48A2-8AF3-D2651E05EAF6Q39579486-9B18699B-DA38-4AC7-98F0-D435EF0194B3Q40105941-4BB44E71-99C8-4723-803D-73C88A6D5718Q41779474-E6F41382-87C9-4BEB-8088-4196391DEA7EQ41989956-B4A63EB2-B1CF-4143-856E-B91DF3782B88Q42158862-F12AB138-FCF2-48EA-818D-2D2DBE67562CQ43230854-5EAC0DC1-0A0F-4170-9E86-AD4C5EEE0C8EQ43289086-F6C1A649-2CF4-4200-960E-48B8639ECB16Q43494364-133D7985-4B85-42E9-AFB0-308C417A2959Q48273811-7DD51ADC-507F-4734-8205-258F1AB86172Q48376807-AE05DF29-0A40-4A41-9E43-114554290976Q58790015-F986A47F-651F-48FF-8036-DA425E4A69B8
P2860
Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Duodenal administration of sol ...... ent percentages of tobramycin.
@en
Duodenal administration of sol ...... ent percentages of tobramycin.
@nl
type
label
Duodenal administration of sol ...... ent percentages of tobramycin.
@en
Duodenal administration of sol ...... ent percentages of tobramycin.
@nl
prefLabel
Duodenal administration of sol ...... ent percentages of tobramycin.
@en
Duodenal administration of sol ...... ent percentages of tobramycin.
@nl
P2093
P356
P1476
Duodenal administration of sol ...... ent percentages of tobramycin.
@en
P2093
Alessandro Bargoni
Elisabetta Muntoni
Gian Paolo Zara
Maria Rosa Gasco
Roberta Cavalli
Valerio Podio
P304
P356
10.1002/JPS.10368
P407
P577
2003-05-01T00:00:00Z